Ir al menú de navegación principal Ir al contenido principal Ir al pie de página del sitio

Perforación intestinal relacionada con ipilimumab.

Bowel perforation related with ipilimumab.



Abrir | Descargar


Sección
Imágenes en hematología y oncología

Cómo citar
Perforación intestinal relacionada con ipilimumab.
Rev. colomb. hematol. oncol. [Internet]. 2012 Apr. 1 [cited 2024 Dec. 21];1(1):67-9. Disponible en: https://doi.org/10.51643/22562915.290

Dimensions
PlumX
Licencia
Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.

Andrea Robayo
    Marcela Mejía
      Andrés Felipe Cardona
        Henry Becerra
          Jorge Miguel Otero

            Andrea Robayo,

            Medicine Faculty, Universidad de los Andes, Hospital Universitario Fundación Santa Fe de Bogotá (Bogotá, Colombia).


            Marcela Mejía,

            Laboratory and Pathology Department, Fundación Santa Fe de Bogotá (Bogotá, Colombia).


            Andrés Felipe Cardona,

            Clinical and Translational Oncology Group, Institute of Oncology, Fundación Santa Fe de Bogotá (Bogotá, Colombia). Foundation for Clinical and Applied Cancer Research (FICMAC); associated researcher ONCOLGroup.


            Henry Becerra,

            Clinical and Translational Oncology Group, Institute of Oncology, Fundación Santa Fe de Bogotá (Bogotá, Colombia).


            Jorge Miguel Otero,

            Clinical and Translational Oncology Group, Institute of Oncology, Fundación Santa Fe de Bogotá (Bogotá, Colombia). Foundation for Clinical and Applied Cancer Research (FICMAC); associated researcher ONCOLGroup.


            Hernán Carranza,

            Clinical and Translational Oncology Group, Institute of Oncology, Fundación Santa Fe de Bogotá (Bogotá, Colombia). Foundation for Clinical and Applied Cancer Research (FICMAC); associated researcher ONCOLGroup.


            Carlos Vargas,

            Clinical and Translational Oncology Group, Institute of Oncology, Fundación Santa Fe de Bogotá (Bogotá, Colombia). Foundation for Clinical and Applied Cancer Research (FICMAC); associated researcher ONCOLGroup.


            Javier Carrera,

            Colon and Rectal Surgery Department, Fundación Santa Fe de Bogotá (Bogotá, Colombia).


            A 48-year-old man was admitted to hospital following four days of having suffered diarrhea and a febrile episode on the same day as he consulted. The diarrhea had increased to 6 episodes during the 12 hours before admission, regardless of the administration of loperamide or low doses of dexamethasone. He referred to no other symptoms upon admission.


            Visitas del artículo 100 | Visitas PDF 91


            Sistema OJS 3.4.0.7 - Metabiblioteca |